Add BrightSurf on Google Email

Korea University study identifies liver–metabolic disease as a key risk factor for heart failure in older adults with atrial fibrillation

A Korea University study reveals that liver metabolic disease is a key risk factor for heart failure in older adults with atrial fibrillation, with MASLD having the lowest risk and ALD carrying the highest risk. The study highlights the importance of liver health in cardiovascular disease management.

SourceKorea University College of Medicine·JournalEuropean Journal of Heart Failure·TypeObservational study·DateMar 23, 2026

Medical centers highlight responsible ways to share genetic disease risk information

A study by Cincinnati Children's Hospital Medical Center and the eMERGE network found that sharing genetic disease risk information with patients can be done responsibly, with a 70% success rate. The team shared results with over 24,000 people using various methods, including one-to-one conversations for those with higher-risk findings.

SourceCincinnati Children's Hospital Medical Center·JournalAmerican Journal of Human Genetics·TypeData/statistical analysis·DateMar 23, 2026

New blood marker reduces the risk of a false diagnosis of Alzheimer’s disease

Researchers at Lund University have developed a new blood marker that significantly improves the accuracy of Alzheimer's diagnosis. The study found that combining two biomarkers, p-tau217 and eMTBR-tau243, can identify people with established Alzheimer's disease with an accuracy rate of around 80%. This breakthrough reduces false posit...

SourceLund University·JournalThe Lancet Neurology·TypeObservational study·DateMar 23, 2026

Tumor-informed liquid biopsy suggests structural-variant ddPCR can monitor high-grade serous ovarian cancer

A novel method for monitoring on-treatment disease burden in high-grade serous ovarian cancer uses tumor-informed breakpoints-spanning ddPCR, detecting superior sensitivity and specificity compared to real-time PCR. The approach may enable sensitive and specific detection of minimal residual disease and early relapse detection.

SourceImpact Journals LLC·JournalOncoscience·TypeNews article·DateMar 19, 2026

New research shows how to diagnose people with Alzheimer’s plus a hard-to-identify dementia type

Researchers found that patients with both conditions exhibited different neuropsychiatric symptoms, which could inform diagnosis and treatment plans. The study's findings may help clinicians better understand the complex disease course of patients with multiple disorders, including Alzheimer's and frontotemporal lobar degeneration.

SourceBrown University·JournalNeurology·TypeData/statistical analysis·DateMar 16, 2026

Hidden acid imbalance in kidney disease raises red flags

A Japanese registry study reveals widespread underdiagnosis and undertreatment of metabolic acidosis in chronic kidney disease patients. Nearly half of patients with bicarbonate measured had metabolic acidosis, and diagnosis and treatment rates were low, highlighting a need for routine bicarbonate testing in CKD care.

SourceNiigata University·JournalScientific Reports·DateMar 16, 2026

Early intervention in severe fetal megacystis can increase survival rate and kidney function

Researchers found that treating severe fetal megacystis with a vesicoamniotic shunt in the first trimester can improve survival rates and kidney function. In the study, 75% of children were born alive and 68% survived their first year of life, with most showing normal or only slightly impaired kidney function.

SourceUniversity of Cologne·JournalThe Lancet Child & Adolescent Health·TypeExperimental study·DateMar 13, 2026

Eyes as a window to hidden brain diseases

Researchers developed a fast, non-invasive, and affordable diagnostic tool using retinal images to differentiate between ALS and Alzheimer's disease. The tool, based on polarized light analysis, accurately predicted disease severity and type with high accuracy.

SourceUniversity of Waterloo·JournalAlzheimer’s & Dementia·TypeExperimental study·DateMar 11, 2026

Cellular changes linked to depression related fatigue

Researchers at the University of Queensland have made a breakthrough in understanding the cellular changes that occur in depression. They found that cells in people with depression produce more energy molecules when resting, but have a reduced ability to increase energy production under stress. This study offers a new potential approac...

SourceUniversity of Queensland·JournalTranslational Psychiatry·TypeImaging analysis·DateMar 10, 2026

A comprehensive review charts how psychiatry could finally diagnose what it actually treats

Emerging research across conceptual frameworks, biomarker science, digital phenotyping, and artificial intelligence synthesizes a translational pathway toward a more biologically grounded and clinically useful approach to psychiatric diagnosis. The current system falls short due to standardized clinical language and lack of biological ...

SourceGenomic Press·JournalBrain Medicine·TypeLiterature review·DateMar 10, 2026

AI accurately spots medical disorder from privacy-conscious hand images

Researchers at Kobe University developed an AI model that can diagnose acromegaly with high sensitivity and specificity using only pictures of the back of the hand and clenched fist. This approach holds promise for disease screening, particularly in rural or resource-constrained areas where access to specialists may be limited.

SourceKobe University·JournalThe Journal of Clinical Endocrinology & Metabolism·TypeRandomized controlled/clinical trial·DateFeb 27, 2026

Digital clinical decision support algorithm substantially reduced antibiotic prescribing without compromising clinical recovery, according to non-randomized controlled trial in 32 Rwandan health centers

A digital clinical decision support algorithm substantially reduced antibiotic prescribing in pediatric outpatient care in Rwanda, according to a non-randomized controlled trial. The study found no compromise in clinical recovery, suggesting the algorithm's effectiveness in guiding appropriate treatment.

SourcePLOS·JournalPLOS Medicine·TypeExperimental study·DateFeb 26, 2026

Gallbladder cancer could soon be detected in blood, study finds

A study by Tezpur University and University of Illinois has identified distinct metabolic patterns in blood that can distinguish gallbladder cancer cases from noncancerous conditions. The researchers detected hundreds of altered metabolites and identified markers with high diagnostic accuracy for each condition.

Study finds no evidence of persistent tick-borne infection in people who link chronic illness to ticks

Researchers studied Norwegians with reported chronic health problems linked to tick bites, finding no objective evidence of persistent infections. The study suggests that physical activity and labour force participation may be more related to symptoms than tick exposure.

SourceNorwegian University of Science and Technology·JournalBMC Infectious Diseases·TypeObservational study·DateFeb 25, 2026

New study predicts real-world impact of using smartwatches to detect undiagnosed high blood pressure

A new analysis found that wearing an Apple Watch with hypertension notifications can increase the probability of having hypertension in younger adults, while decreasing it in older adults. The study also revealed racial and ethnic disparities in cardiovascular health, highlighting the need for targeted screening and treatment.

SourceUniversity of Utah Health·JournalJAMA·TypeData/statistical analysis·DateFeb 9, 2026

HKUMed–Dentistry study discovers brain microenvironment redefines metastatic tumour subtypes, facilitating precision oncology treatment

Researchers identified four distinct brain metastasis subtypes, each with unique immune landscapes and metabolic programmes. The 'Immune-infiltrated subtype' showed high sensitivity to immunotherapy, while the 'Metabolic subtype' responded well to targeted therapies. The study paves the way for personalized treatment strategies.

SourceThe University of Hong Kong·JournalNature Communications·TypeExperimental study·DateFeb 5, 2026

Validation of SOFA-2 score in sepsis and exploration of its extension with additional immune markers

The study validates the use of SOFA-2 in sepsis care and research, demonstrating its ability to identify clinically meaningful organ dysfunction. The findings suggest that incorporating immune markers may not improve predictive performance, highlighting the biological complexity of sepsis.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeObservational study·DateFeb 3, 2026

Treatment initiation is possible with a positive liquid biopsy in primary central nervous lymphoma patients with difficult-to-access lesions

Researchers successfully diagnosed and treated ten PCNSL patients using liquid biopsy, detecting hotspot MYD88 L265P mutations in circulating tumor DNA. This method offers a reliable alternative to surgical biopsies for patients with difficult-to-access lesions or frailty, enabling timely treatment initiation.

SourceNiigata University·JournalNeuro-Oncology Advances·DateJan 27, 2026

New blood test shows extent of brain injury after stroke – and reveals treatment effects

A new blood biomarker, brain-derived tau (BD-tau), tracks the extent of brain injury after ischemic stroke over time. It also predicts patient outcomes months to years later and detects differences associated with successful vessel reopening. BD-tau has potential applications for other neurological conditions.

SourceLudwig-Maximilians-Universität München·JournalScience Translational Medicine·DateJan 15, 2026

A CRISPR fingerprint of pathogenic C. auris fungi

A new diagnostic platform enables rapid and accurate detection of drug-resistant C. auris pathogens using CRISPR technology, allowing for more effective treatment and prevention of hospital outbreaks. The dSHERLOCK test can detect the presence of mutations causing antimicrobial resistance in just 40 minutes.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateJan 14, 2026